top of page

BLUEBERRIES MEDICAL CORP ANNUAL GENERAL MEETING 2022

BBM - PR 2022.11.28 Private Placement & FS Q3 2022

BBM MDA Q3 2022 FINAL (221128)

BBM FS Q3 2022
FINAL (221128)

INFORMACIÓN
GENERAL

Blueberries Medical Corp. es una compañía latinoamericana con todas las licencias otorgadas por los Ministerios de Justicia y Salud de Colombia, necesarias para producir cannabis de alta calidad, con bajos y altos contenidos de THC. Produce, comercializa, y exportar ingredientes derivados de Cannabis. Sus operaciones se centran principalmente en la Sabana de Bogotá, en el centro de Colombia.

​

Blueberries Medical Corp cotiza en los siguientes mercados: (CSE: BBM) (OTC: BBRRF) (FRA: 1OA)

PRESENTACIÓN INVERSIONISTAS

2021

Q3 2021

Condensed Interim Consolidated Financial Statements For The Three Months Ended September 30, 2021 And 2020

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended September 30, 2021

Q2 2021

Condensed Interim Consolidated Financial Statements For The Three Months Ended June 30, 2021 And 2020

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended June 30, 2021

Q1 2021

Condensed Interim Consolidated Financial Statements For The Three Months Ended March 31, 2021 And 2020

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended March 31, 2021

RELACIÓN CON INVERSIONISTAS

Guillermo Rodriguez

CFO 

     grodriguez@blueberriesmed.com

     +54 91160152227

STOCK INFORMATION
bottom of page